APOE and coronary artery disorder: In conclusion, we identified two circulating miRNAs, miR-486 and miR-92a, which together with apolipoproteins (apoA-I, apoE), PON1 activity and the ratio HDL/LDL cholesterol, can be used as an additional tool to designate vulnerable CAD patients.